BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cleeland CS, Allen JD, Roberts SA, Brell JM, Giralt SA, Khakoo AY, Kirch RA, Kwitkowski VE, Liao Z, Skillings J. Reducing the toxicity of cancer therapy: recognizing needs, taking action. Nat Rev Clin Oncol 2012;9:471-8. [DOI: 10.1038/nrclinonc.2012.99] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Backendorf C, Noteborn MHM. Apoptin Towards Safe and Efficient Anticancer Therapies. In: Grimm S, editor. Anticancer Genes. London: Springer; 2014. pp. 39-59. [DOI: 10.1007/978-1-4471-6458-6_3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Ye D, Ma Y, Zhao W, Cao H, Kong J, Xiong H, Möhwald H. ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects. ACS Nano 2016;10:4294-300. [DOI: 10.1021/acsnano.5b07846] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 11.3] [Reference Citation Analysis]
3 Hoang JM, Upadhyay N, Dike DN, Lee J, Johnson ML, Cleeland CS, Mendoza T, Chen H, Trivedi MV. Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients. Support Care Cancer 2020;28:1809-16. [PMID: 31338641 DOI: 10.1007/s00520-019-05004-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Mukha A, Dubrovska A. Metabolic Targeting of Cancer Stem Cells. Front Oncol. 2020;10:537930. [PMID: 33415069 DOI: 10.3389/fonc.2020.537930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Dora NO, Blackburn E, Boles JE, Williams GT, White LJ, Turner SEG, Hothersall JD, Askwith T, Doolan JA, Mulvihill DP, Garrett MD, Hiscock JR. Supramolecular self-associating amphiphiles (SSAs) as nanoscale enhancers of cisplatin anticancer activity. RSC Adv 2021;11:14213-7. [DOI: 10.1039/d1ra02281d] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Alessi I, Caroleo AM, de Palma L, Mastronuzzi A, Pro S, Colafati GS, Boni A, Della Vecchia N, Velardi M, Evangelisti M, Carboni A, Carai A, Vinti L, Valeriani M, Reale A, Parisi P, Raucci U. Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System Damage. Cancers 2022;14:1540. [DOI: 10.3390/cancers14061540] [Reference Citation Analysis]
7 Pettit SD, Silberman P, Hassmiller Lich K, Kirch RA, Lipshultz SE, Teal R, Basch E. Stakeholder perspectives on addressing adverse events from adjuvant cancer therapy: A qualitative study. Cancer 2019;125:4471-80. [PMID: 31454424 DOI: 10.1002/cncr.32448] [Reference Citation Analysis]
8 Roswall N, Bidstrup PE, Raaschou-Nielsen O, Solvang Jensen S, Overvad K, Halkjær J, Sørensen M. Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study. PLoS One 2017;12:e0187161. [PMID: 29084272 DOI: 10.1371/journal.pone.0187161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Spiegel D, Riba MB. Managing anxiety and depression during treatment. Breast J 2015;21:97-103. [PMID: 25377647 DOI: 10.1111/tbj.12355] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
10 Sun Z, Schriewer J, Tang M, Marlin J, Taylor F, Shohet RV, Konorev EA. The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells. J Mol Cell Cardiol 2016;90:129-38. [PMID: 26686989 DOI: 10.1016/j.yjmcc.2015.12.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
11 Sjøblom B, Benth JŠ, Grønberg BH, Baracos VE, Sawyer MB, Fløtten Ø, Hjermstad MJ, Aass N, Jordhøy M. Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2017;18:e129-36. [DOI: 10.1016/j.cllc.2016.09.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
12 Blumenfeld CM, Schulz MD, Aboian MS, Wilson MW, Moore T, Hetts SW, Grubbs RH. Drug capture materials based on genomic DNA-functionalized magnetic nanoparticles. Nat Commun 2018;9:2870. [PMID: 30030447 DOI: 10.1038/s41467-018-05305-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zhang Q, Wu J, Wang J, Wang X, Wu C, Chen M, Wu Q, Lesniak MS, Mi Y, Cheng Y, Wang Q. A Neutrophil-Inspired Supramolecular Nanogel for Magnetocaloric-Enzymatic Tandem Therapy. Angew Chem Int Ed Engl 2020;59:3732-8. [PMID: 31834981 DOI: 10.1002/anie.201915118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
14 Pas R, Leysen L, De Goeij W, Vossebeld L, Van Wilgen P, De Groef A, De Kooning M. Pain Neuroscience Education in cancer survivors with persistent pain: A pilot study. J Bodyw Mov Ther 2020;24:239-44. [PMID: 33218517 DOI: 10.1016/j.jbmt.2020.06.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Barreto R, Waning DL, Gao H, Liu Y, Zimmers TA, Bonetto A. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs. Oncotarget 2016;7:43442-60. [PMID: 27259276 DOI: 10.18632/oncotarget.9779] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 15.6] [Reference Citation Analysis]
16 Woopen H, Sehouli J, Davis A, Lee YC, Cohen PA, Ferrero A, Gleeson N, Jhingran A, Kajimoto Y, Mayadev J, Barretina-Ginesta MP, Sundar S, Suzuki N, van Dorst E, Joly F. GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee. Cancer Treat Rev 2022;107:102396. [PMID: 35525106 DOI: 10.1016/j.ctrv.2022.102396] [Reference Citation Analysis]
17 Li F, Nie W, Zhang F, Lu G, Lv C, Lv Y, Bao W, Zhang L, Wang S, Gao X, Wei W, Xie HY. Engineering Magnetosomes for High-Performance Cancer Vaccination. ACS Cent Sci 2019;5:796-807. [PMID: 31139716 DOI: 10.1021/acscentsci.9b00060] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
18 Li Y, Qu J, Zhang P, Zhang Z. Reduction-responsive sulfur dioxide polymer prodrug nanoparticles loaded with irinotecan for combination osteosarcoma therapy. Nanotechnology 2020;31:455101. [PMID: 32688350 DOI: 10.1088/1361-6528/aba783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Kaur J, Bhattacharyya S. Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy. Front Oncol 2021;11:756888. [PMID: 34804950 DOI: 10.3389/fonc.2021.756888] [Reference Citation Analysis]
20 Hain BA, Xu H, Waning DL. Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice. J Cachexia Sarcopenia Muscle 2021;12:1597-612. [PMID: 34664403 DOI: 10.1002/jcsm.12795] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang X, Liu X, Jia Z, Zhang Y, Wang S, Zhang H. Evaluation of the Effects of Different Dietary Patterns on Breast Cancer: Monitoring Circulating Tumor Cells. Foods 2021;10:2223. [PMID: 34574333 DOI: 10.3390/foods10092223] [Reference Citation Analysis]
22 Minasian L, Rosen O, Auclair D, Rahman A, Pazdur R, Schilsky RL. Optimizing dosing of oncology drugs. Clin Pharmacol Ther 2014;96:572-9. [PMID: 25105705 DOI: 10.1038/clpt.2014.153] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
23 Lesko LJ, Zheng S, Schmidt S. Systems approaches in risk assessment. Clin Pharmacol Ther 2013;93:413-24. [PMID: 23531724 DOI: 10.1038/clpt.2013.29] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
24 Volungholen Sollid MI, Kirkevold Ø, Slaaen M, Ervik B, Melby L, Eilertsen G. Experiences of older patients with cancer from the radiotherapy pathway - A qualitative study. Eur J Oncol Nurs 2021;53:101999. [PMID: 34294576 DOI: 10.1016/j.ejon.2021.101999] [Reference Citation Analysis]
25 Aikemu A, Amat N, Yusup A, Shan L, Qi X, Upur H. Attenuation effect of Abnormal Savda Munziq on liver and heart toxicity caused by chemotherapy in mice. Exp Ther Med 2016;12:384-90. [PMID: 27347066 DOI: 10.3892/etm.2016.3328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Zhang B, Lu C, Bai M, He X, Tan Y, Bian Y, Xiao C, Zhang G, Lu A, Li S. Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury. J Ethnopharmacol 2015;175:638-47. [PMID: 26435225 DOI: 10.1016/j.jep.2015.09.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
27 Saltaouras G, Lightowler H, Coe S, Watson EK. Diet and nutrition information and support needs in pelvic radiotherapy: A systematic, mixed-methods review. Eur J Cancer Care (Engl) 2020;29:e13297. [PMID: 32851712 DOI: 10.1111/ecc.13297] [Reference Citation Analysis]
28 Park D. Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest. Biol Pharm Bull 2022;45:184-93. [PMID: 35110505 DOI: 10.1248/bpb.b21-00697] [Reference Citation Analysis]
29 Sorace AG, Syed AK, Barnes SL, Quarles CC, Sanchez V, Kang H, Yankeelov TE. Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer. Mol Imaging Biol 2017;19:130-7. [PMID: 27506906 DOI: 10.1007/s11307-016-0994-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
30 Palesh O, Aldridge-Gerry A, Zeitzer JM, Koopman C, Neri E, Giese-Davis J, Jo B, Kraemer H, Nouriani B, Spiegel D. Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep 2014;37:837-42. [PMID: 24790261 DOI: 10.5665/sleep.3642] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 13.4] [Reference Citation Analysis]
31 Ediriweera MK, Tennekoon KH, Samarakoon SR, Thabrew I, De Silva ED. Induction of Apoptosis in MCF-7 Breast Cancer Cells by Sri Lankan Endemic Mango ( Mangifera zeylanica ) Fruit Peel through Oxidative Stress and Analysis of its Phytochemical Constituents: Anticancer Effects of Mangifera zeylanica Peel. Journal of Food Biochemistry 2017;41:e12294. [DOI: 10.1111/jfbc.12294] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
32 Conte E, Bresciani E, Rizzi L, Cappellari O, De Luca A, Torsello A, Liantonio A. Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies. Int J Mol Sci 2020;21:E1242. [PMID: 32069876 DOI: 10.3390/ijms21041242] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
33 Bao W, Liu M, Meng J, Liu S, Wang S, Jia R, Wang Y, Ma G, Wei W, Tian Z. MOFs-based nanoagent enables dual mitochondrial damage in synergistic antitumor therapy via oxidative stress and calcium overload. Nat Commun 2021;12:6399. [PMID: 34737274 DOI: 10.1038/s41467-021-26655-4] [Reference Citation Analysis]
34 Hilton KLF, Manwani C, Boles JE, White LJ, Ozturk S, Garrett MD, Hiscock JR. The phospholipid membrane compositions of bacterial cells, cancer cell lines and biological samples from cancer patients. Chem Sci 2021;12:13273-82. [PMID: 34777745 DOI: 10.1039/d1sc03597e] [Reference Citation Analysis]
35 Palesh O, Scheiber C, Kesler S, Mustian K, Koopman C, Schapira L. Management of side effects during and post-treatment in breast cancer survivors. Breast J 2018;24:167-75. [DOI: 10.1111/tbj.12862] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
36 George GC, Barata PC, Campbell A, Chen A, Cortes JE, Hyman DM, Jones L, Karagiannis T, Klaar S, Le-rademacher JG, Lorusso P, Mandrekar SJ, Merino DM, Minasian LM, Mitchell SA, Montez S, O'connor DJ, Pettit S, Silk E, Sloan JA, Stewart M, Takimoto CH, Wong GY, Yap TA, Cleeland CS, Hong DS. Improving attribution of adverse events in oncology clinical trials. Cancer Treatment Reviews 2019;76:33-40. [DOI: 10.1016/j.ctrv.2019.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
37 Liu Z, Fang H, Slikker W, Tong W. Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases. Trends in Pharmacological Sciences 2016;37:843-57. [DOI: 10.1016/j.tips.2016.06.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
38 Son DS, Lee ES, Adunyah SE. The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs. Immune Netw 2020;20:e29. [PMID: 32895616 DOI: 10.4110/in.2020.20.e29] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
39 Geng B, Qin H, Shen W, Li P, Fang F, Li X, Pan D, Shen L. Carbon dot/WS2 heterojunctions for NIR-II enhanced photothermal therapy of osteosarcoma and bone regeneration. Chemical Engineering Journal 2020;383:123102. [DOI: 10.1016/j.cej.2019.123102] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 10.5] [Reference Citation Analysis]
40 Chis AA, Dobrea C, Morgovan C, Arseniu AM, Rus LL, Butuca A, Juncan AM, Totan M, Vonica-Tincu AL, Cormos G, Muntean AC, Muresan ML, Gligor FG, Frum A. Applications and Limitations of Dendrimers in Biomedicine. Molecules 2020;25:E3982. [PMID: 32882920 DOI: 10.3390/molecules25173982] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
41 Bahamin N, Ahmadian S, Rafieian-Kopaei M, Mobini G, Shafiezadeh M, Soltani A. A Comparative Study on Anticancer Effects of the Alhagi maurorum and Amygdalus haussknechtii Extracts Alone and in Combination with Docetaxel on 4T1 Breast Cancer Cells. Evid Based Complement Alternat Med 2021;2021:5517944. [PMID: 34221071 DOI: 10.1155/2021/5517944] [Reference Citation Analysis]
42 Valderrama A, Reynoso R, Gómez RW, Marquina V. Self-stability of C60 nanocapsules with radio-iodide content and its interaction with calcium atoms. J Mol Model 2016;22:28. [PMID: 26748925 DOI: 10.1007/s00894-015-2898-4] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Valderrama A, Guzman J. Encapsulation of sodium radio-iodide in fullerene C₆₀. J Mol Model 2014;20:2130. [PMID: 24577556 DOI: 10.1007/s00894-014-2130-y] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
44 Pettit SD, Lipshultz SE, Cleeland CS, Roberts S, Davis M, Berridge BR, Kirch RA. Enhancing quality of life as a goal for anticancer therapeutics. Sci Transl Med 2016;8:344ed9. [PMID: 27334258 DOI: 10.1126/scitranslmed.aag0382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
45 Dry JR, Yang M, Saez-Rodriguez J. Looking beyond the cancer cell for effective drug combinations. Genome Med 2016;8:125. [PMID: 27887656 DOI: 10.1186/s13073-016-0379-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
46 Song H, Peng T, Wang X, Li B, Wang Y, Song D, Xu T, Liu X. Glutathione-Sensitive Mesoporous Organosilica-Coated Gold Nanorods as Drug Delivery System for Photothermal Therapy-Enhanced Precise Chemotherapy. Front Chem 2022;10:842682. [DOI: 10.3389/fchem.2022.842682] [Reference Citation Analysis]
47 Hersant B, Werkoff G, Sawan D, Sidahmed-Mezi M, Bosc R, La Padula S, Kalsoum S, Ouidir N, Meningaud JP, Belkacemi Y. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial. Ann Chir Plast Esthet 2020;65:e23-31. [PMID: 32513482 DOI: 10.1016/j.anplas.2020.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
48 Laviano A, Rianda S, Molfino A, Fanelli FR. Omega-3 fatty acids in cancer: . Current Opinion in Clinical Nutrition and Metabolic Care 2013;16:156-61. [DOI: 10.1097/mco.0b013e32835d2d99] [Cited by in Crossref: 83] [Cited by in F6Publishing: 35] [Article Influence: 9.2] [Reference Citation Analysis]
49 Ramdas P, Radhakrishnan AK, Abdu Sani AA, Kumari M, Anandha Rao JS, Abdul-Rahman PS. Advancing the Role of Gamma-Tocotrienol as Proteasomes Inhibitor: A Quantitative Proteomic Analysis of MDA-MB-231 Human Breast Cancer Cells. Biomolecules 2019;10:E19. [PMID: 31877708 DOI: 10.3390/biom10010019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
50 Diefenhardt M, Ludmir EB, Hofheinz RD, Ghadimi M, Minsky BD, Rödel C, Fokas E. Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer: A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. JAMA Oncol 2020;6:1416-21. [PMID: 32644104 DOI: 10.1001/jamaoncol.2020.2394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Laviano A, Molfino A, Fanelli FR. Cancer-treatment toxicity: can nutrition help? Nat Rev Clin Oncol 2012;9:605-605. [DOI: 10.1038/nrclinonc.2012.99-c1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
52 Xu R, Wang Q. Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA Adverse Event Reporting System (FAERS). J Biomed Inform 2014;47:171-7. [PMID: 24177320 DOI: 10.1016/j.jbi.2013.10.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
53 Prado CM. Body composition in chemotherapy: the promising role of CT scans. Current Opinion in Clinical Nutrition and Metabolic Care 2013;16:525-33. [DOI: 10.1097/mco.0b013e328363bcfb] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
54 Nencioni A, Caffa I, Cortellino S, Longo VD. Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer 2018;18:707-19. [PMID: 30327499 DOI: 10.1038/s41568-018-0061-0] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 41.3] [Reference Citation Analysis]
55 Pettit SD, Kirch R. Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors? Cardiooncology 2018;4:5. [PMID: 32154005 DOI: 10.1186/s40959-018-0031-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Koh J, Itahana Y, Mendenhall IH, Low D, Soh EXY, Guo AK, Chionh YT, Wang LF, Itahana K. ABCB1 protects bat cells from DNA damage induced by genotoxic compounds. Nat Commun 2019;10:2820. [PMID: 31249297 DOI: 10.1038/s41467-019-10495-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Mir O, Coriat R. Aprepitant for pruritus: drug–drug interactions matter. The Lancet Oncology 2012;13:964-5. [DOI: 10.1016/s1470-2045(12)70397-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
58 Pin F, Couch ME, Bonetto A. Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition. Curr Opin Support Palliat Care 2018;12:420-6. [PMID: 30124526 DOI: 10.1097/SPC.0000000000000382] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 10.7] [Reference Citation Analysis]
59 van Rossum AGJ, Kok M, McCool D, Opdam M, Miltenburg NC, Mandjes IAM, van Leeuwen-Stok E, Imholz ALT, Portielje JEA, Bos MMEM, van Bochove A, van Werkhoven E, Schmidt MK, Oosterkamp HM, Linn SC. Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy. Oncotarget 2017;8:113531-42. [PMID: 29371927 DOI: 10.18632/oncotarget.22697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
60 Chan C, Guo N, Duan X, Han W, Xue L, Bryan D, Wightman SC, Khodarev NN, Weichselbaum RR, Lin W. Systemic miRNA delivery by nontoxic nanoscale coordination polymers limits epithelial-to-mesenchymal transition and suppresses liver metastases of colorectal cancer. Biomaterials 2019;210:94-104. [PMID: 31060867 DOI: 10.1016/j.biomaterials.2019.04.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
61 Sreekanth V, Bajaj A. Recent Advances in Engineering of Lipid Drug Conjugates for Cancer Therapy. ACS Biomater Sci Eng 2019;5:4148-66. [DOI: 10.1021/acsbiomaterials.9b00689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
62 Yee DW, Hetts SW, Greer JR. 3D-Printed Drug Capture Materials Based on Genomic DNA Coatings. ACS Appl Mater Interfaces 2021;13:41424-34. [PMID: 34124877 DOI: 10.1021/acsami.1c05209] [Reference Citation Analysis]
63 Prado CM, Baracos VE, Xiao J, Birdsell L, Stuyckens K, Park YC, Parekh T, Sawyer MB. The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer. Appl Physiol Nutr Metab 2014;39:693-8. [DOI: 10.1139/apnm-2013-0403] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
64 Xu R, Wang Q. Large-scale automatic extraction of side effects associated with targeted anticancer drugs from full-text oncological articles. J Biomed Inform 2015;55:64-72. [PMID: 25817969 DOI: 10.1016/j.jbi.2015.03.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
65 Seluanov A, Gladyshev VN, Vijg J, Gorbunova V. Mechanisms of cancer resistance in long-lived mammals. Nat Rev Cancer 2018;18:433-41. [PMID: 29622806 DOI: 10.1038/s41568-018-0004-9] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 28.7] [Reference Citation Analysis]
66 Celio L, Ricchini F, De Braud F. Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting. Patient Prefer Adherence 2013;7:391-400. [PMID: 23687442 DOI: 10.2147/PPA.S31288] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]